11. OP0064 Joint EULAR/ERA-EDTA recommendations for the management of adult and pediatric lupus nephritis. (23rd January 2014) Authors: Bertsias, G.; Tektonidou, M.; Amoura, Z.; Aringer, M.; Bajema, I.; Berden, J.; Boletis, J.; Cervera, R.; Dörner, T.; Doria, A.; Ferrario, F.; Flöge, J.; Houssiau, F.; Ioannidis, J.P.; Isenberg, D.; Kallenberg, C.G.; Lightstone, L.; Marks, S.; Martini, A.; Moroni, G. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
12. OP0086 Eular Recommendations for Women's Health and the Management of Family Planning, Assisted Reproduction, Pregnancy, and Menopause in Patients With Systemic Lupus Erythematosus and/or the Antiphospholipid Syndrome. (9th June 2015) Authors: Andreoli, L.; Bertsias, G.; Agmon-Levin, N.; Brown, S.; Cervera, R.; Costedoat-Chalumeau, N.; Doria, A.; Fischer-Betz, R.; Forger, F.; Moraes-Fontes, M.; Khamashta, M.; King, J.; Lojacono, A.; Marchiori, F.; Meroni, P.; Mosca, M.; Motta, M.; Ostensen, M.; Pamfil, C.; Raio, L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
13. OP0092 Remission in Sle: Consensus Findings from a Large International Panel on Definitions of Remission in SLE (DORIS). (9th June 2015) Authors: van Vollenhoven, R.F.; Aranow, C.; Bertsias, G.; Bonfá, E.; Cervera, R.; Costedoat-Chalumeau, N.; Dörner, T.; Houssiau, F.; Lerstrom, K.; Morand, E.; Mosca, M.; Navarra, S.; Petri, M.; Urowitz, M.; Voskuijl, A.; Voss, A.; Ward, M.; Werth, V.; Schneider, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 103 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
14. OP0137 GENOME-WIDE WHOLE-BLOOD TRANSCRIPTOME PROFILING IN A LARGE EUROPEAN COHORT OF SYSTEMIC SCLEROSIS PATIENTS. (2nd June 2020) Authors: Beretta, L.; Barturen, G.; Vigone, B.; Bellocchi, C.; Hunzelmann, N.; Delanghe, E.; Kovács, L.; Cervera, R.; Gerosa, M.; Ortega Castro, R.; Almeida, I.; Cornec, D.; Chizzolini, C.; Pers, J. O.; Makowska, Z.; Buttgereit, A.; Lesche, R.; Kerick, M.; Alarcon-Riquelme, M.; Martin Ibanez, J. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
15. OP0223 Significance of IGG Phosphatidylserine-Dependent Antiprothrombin Antibody Testing for the Diagnosis of Antiphospholipid Syndrome: Results from the Initial and Validation International Multi-Centre Studies. (9th June 2015) Authors: Amengual, O.; Forastiero, R.; Sugiura-Ogasawara, M.; Otomo, K.; Kenji, O.; Favas, C.; Delgado Alves, J.; Žigon, P.; Ambrožič, A.; Tomšič, M.; Ruiz Arruza, I.; Ruiz Irastorza, G.; Bertolaccini, M.L.; Norman, G.L.; Shums, Z.; Jiro, A.; Murashima, A.; Tebo, A.E.; Gerosa, M.; Meroni, P.L. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
16. OP0265 A 24-Hour Proteinuria Cutoff Level of 0.7 Gram After 12 Months of Treatment Best Predicts Long-Term Renal Outcome in Lupus Nephritis: Data from the Maintain Nephritis Trial. (9th June 2015) Authors: Tamirou, F.; Lauwerys, B.R.; Dall'Era, M.; Mackay, M.; Rovin, B.; Cervera, R.; Houssiau, F.A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 172 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
17. Rheumatology. Issue 784 (February 1991) Authors: Asherson, R. A.; Cervera, R.; D'Cruz, D. P.; Hughes, G. R. Journal: Postgraduate medical journal Issue: Volume 67:Issue 784(1991) Page Start: 114 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
18. SAT0197 Baseline laboratory characteristics from the combined placebo groups in the bliss trials are predictive of severe flare at 24 weeks. (23rd January 2014) Authors: Petri, M.; van Vollenhoven, R.F.; Levy, R.A.; Navarra, S.; Cervera, R.; Zhong, Z.J.; Freimuth, W.; Buyon, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 538 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
19. SAT0204 Predictors for SLE flares: Baseline disease activity and demographic characteristics from the bliss trials' combined placebo groups. (23rd January 2014) Authors: van Vollenhoven, R.F.; Petri, M.; Levy, R.A.; Navarra, S.; Buyon, J.; Zhong, Z.J.; Freimuth, W.; Cervera, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 540 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
20. SAT0350 Bone mineral density in lupus erythematosus women 1 year after rituximab therapy. (23rd January 2014) Authors: Garcia-Carrasco, M.; Mendoza-Pinto, C.; Etchegaray-Morales, I.; Jimenez-Hernandez, C.; Rodriguez-Gallego, A.B.; Briones-Rojas, R.; Ordoñez-Andrade, E.; Mendez-Martinez, S.; Aguilar-Cuenca, J.E.; Cervera, R. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗